DMAC — DiaMedica Therapeutics Share News
0.000.00%
Last trade - 00:00- $513.37m
- $469.88m
DiaMedica Therapeutics Inc expected to post a loss of 18 cents a share - Earnings Preview
DiaMedica Therapeutics Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: Diamedica Therapeutics Files For Shelf Of Up To 11 Million Common Shares By Selling Shareholders - SEC Filing
Brief: Diamedica Therapeutics Announces Closing Of $37.5 Million Private Placement
Brief: DiaMedica Therapeutics Announces $37.5 Mln Private Placement
Brief: DiaMedica Therapeutics Announces That The FDA Has Removed The Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Stroke
Brief: DiaMedica Therapeutics Files Complete Clinical Hold Response With FDA On Phase 2/3 Clinical Trial Of DM199
DiaMedica Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Diamedica Therapeutics Provides A Business Update And Announces First Quarter 2023 Financial Results
DiaMedica Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
DiaMedica Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
DiaMedica Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
DiaMedica Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: DiaMedica Therapeutics Announces Full Year 2022 Results
DiaMedica Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Diamedica Therapeutics To Report Fourth Quarter 2023 Results
DiaMedica Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
DiaMedica Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Diamedica Therapeutics Announces Third Quarter 2022 Financial Results